This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Nov;123(2):426; author reply 427.

doi: 10.1016/j.ygyno.2011.07.036. Epub 2011 Aug 16.

Early stage ovarian cancers: angiogenesis inhibition and clear cell cancers

Ganessan Kichenadasse, Shawgi Sukumaran, Christos Karapetis

PMID: 21846574
DOI: 10.1016/j.ygyno.2011.07.036

Comment

Early stage ovarian cancers: angiogenesis inhibition and clear cell cancers

Ganessan Kichenadasse et al. Gynecol Oncol. 2011 Nov.

. 2011 Nov;123(2):426; author reply 427.

doi: 10.1016/j.ygyno.2011.07.036. Epub 2011 Aug 16.

Authors

Ganessan Kichenadasse, Shawgi Sukumaran, Christos Karapetis

PMID: 21846574
DOI: 10.1016/j.ygyno.2011.07.036

No abstract available

PubMed Disclaimer

Comment on

A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study.
Mannel RS, Brady MF, Kohn EC, Hanjani P, Hiura M, Lee R, Degeest K, Cohn DE, Monk BJ, Michael H. Mannel RS, et al. Gynecol Oncol. 2011 Jul;122(1):89-94. doi: 10.1016/j.ygyno.2011.03.013. Epub 2011 May 6. Gynecol Oncol. 2011. PMID: 21529904 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science